Please wait while we retrieve your external webpage

With New Blood Test, Roche Dives Deeper Into Personal Cancer Care

One thought on “With New Blood Test, Roche Dives Deeper Into Personal Cancer Care

  1. From a payer perspective, I do not think the clinical utility of the liquid biopsy has been show to warrant wide spread coverage. While I am a proponent of the liquid biopsy, I do not think it has gain “prime time” status. It has shown utility in only a few solid tumors, those of which are know to be active cell shedders. It will be interesting to see if payers will pick up coverage of the test.

Leave a Reply